Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Government Affairs: A Marathon, Not a Sprint

Donald Miller, PharmD  |  Issue: July 2024  |  June 10, 2024

As my tenure on the ACR Government Affairs Committee (GAC) draws to a close, I have been ruminating on the pace of change in government. It has been both a challenging and a satisfying experience. One of the most frustrating things about contacting your elected representatives, even when you visit them in person, is that you almost never get a promise to take immediate action on an issue. Frequently, your senator or representative (or their staff) will promise to look into the issue. Then, on a long flight home, you wonder if all your effort was a waste of time.

Some analogies from my career as a clinician, educator and researcher make me take a more positive view.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As a teacher, especially in a classroom setting, I wonder at times if I have gotten through to a class at all. Were the students really listening or caring about the material, or were they bored and distracted by their electronic devices? Yet at the end of a course, at graduation or even much later, I often meet students who say they really did use the material in practice. Sometimes they will even say, “You were my favorite teacher, and you inspired me to pursue a similar career.”

In patient care, it is often difficult to know if we made a difference until time passes and our patient has made a slow, but real, improvement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

And in research of course, we may run into such roadblocks as missing a grant, slow progress on work, long review times for a research article or outright project failure. But we continue, nonetheless.

Donald Miller, PharmD

And so it is in lobbying your representatives: It is not one email or one visit on the Hill that makes Congress take an action, but the slow, cumulative impact of hundreds of constituents’ contacts.

The Long View

From my current perspective of Capitol Hill visits over six years, I find it interesting to realize how much legislative action has actually occurred on issues of importance to the ACR and ARP.

In just the past three years, legislation has passed on the following issues that we have brought to the attention of Congress:

  • In August 2022, the Inflation Reduction Act capped Medicare Part D out-of-pocket costs at $2,000 annually.
  • The FY2022 Congressional Funding Bill funded the pediatric loan repayment program for the first time.
  • In September 2022, the Improving Seniors’ Timely Access to Care Act passed the House, prompting the Centers for Medicare & Medicaid Services (CMS) to adopt its provisions into a rule it published in 2023.
  • In March 2024, the Conrad State 30 and Physician Access Reauthorization Act passed. This extended the Conrad 30 program, which allows J-1 foreign medical graduates to apply for a waiver of the two-year foreign residence requirement upon completion of a J-1 exchange program.
  • Also in March 2024, the National Defense Authorization Act of 2024 included a line item for arthritis research in the Congressionally Directed Medical Research Programs at the Department of Defense.

 

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:ACR advocacyGovernment Affairs Committee (GAC)

Related Articles

    The 2022 ARP President’s & Merit Awards

    November 6, 2022

    During ACR Convergence 2022 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    The 2019 ARP Awards of Distinction & ACR Masters

    November 16, 2019

    ATLANTA—At the 2019 ACR/ARP Annual Meeting in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find a…

    The 2021 ARP President’s Awards & Merit Awards

    November 14, 2021

    During ACR Convergence 2021 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the winners of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences